LifeStance Health EBITDA 2020-2024 | LFST
LifeStance Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| LifeStance Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-107 |
| 2022 | $-139 |
| 2021 | $-230 |
| 2020 | $47 |
| 2019 | $22 |
| LifeStance Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $16 |
| 2024-06-30 | $3 |
| 2024-03-31 | $6 |
| 2023-12-31 | $-10 |
| 2023-09-30 | $-54 |
| 2023-06-30 | $-28 |
| 2023-03-31 | $-14 |
| 2022-12-31 | $-27 |
| 2022-09-30 | $-20 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-49 |
| 2021-12-31 | $-98 |
| 2021-09-30 | $-110 |
| 2021-06-30 | $-34 |
| 2021-03-31 | $12 |
| 2020-12-31 | $12 |
| 2020-09-30 | $14 |
| 2020-06-30 | $10 |
| 2020-03-31 | $8 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.698B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.200B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |